HEADER HYDROLASE 19-APR-01 1IHD TITLE CRYSTAL STRUCTURE OF TRIGONAL FORM OF D90E MUTANT OF ESCHERICHIA COLI TITLE 2 ASPARAGINASE II COMPND MOL_ID: 1; COMPND 2 MOLECULE: L-ASPARAGINASE II; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: L-ASNASE II; COMPND 5 EC: 3.5.1.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS L-ASPARAGINASE, LEUKEMIA, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.BOREK,M.JASKOLSKI REVDAT 6 16-AUG-23 1IHD 1 REMARK REVDAT 5 27-OCT-21 1IHD 1 SEQADV REVDAT 4 19-OCT-16 1IHD 1 JRNL REVDAT 3 13-JUL-11 1IHD 1 VERSN REVDAT 2 24-FEB-09 1IHD 1 VERSN REVDAT 1 09-SEP-03 1IHD 0 JRNL AUTH D.BOREK,M.KOZAK,J.PEI,M.JASKOLSKI JRNL TITL CRYSTAL STRUCTURE OF ACTIVE SITE MUTANT OF ANTILEUKEMIC JRNL TITL 2 L-ASPARAGINASE REVEALS CONSERVED ZINC-BINDING SITE. JRNL REF FEBS J. V. 281 4097 2014 JRNL REFN ISSN 1742-464X JRNL PMID 25040257 JRNL DOI 10.1111/FEBS.12906 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.L.SWAIN,M.JASKOLSKI,D.HOUSSET,J.K.RAO,A.WLODAWER REMARK 1 TITL CRYSTAL STRUCTURE OF ESCHERICHIA COLI L-ASPARAGINASE, AN REMARK 1 TITL 2 ENZYME USED IN CANCER THERAPY REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 1474 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.J.PALM,J.LUBKOWSKI,C.DERST,S.SCHLEPER,K.H.ROHM,A.WLODAWER REMARK 1 TITL A COVALENTLY BOUND CATALYTIC INTERMEDIATE IN ESCHERICHIA REMARK 1 TITL 2 COLI ASPARAGINASE: CRYSTAL STRUCTURE OF A THR-89-VAL MUTANT REMARK 1 REF FEBS LETT. V. 390 211 1996 REMARK 1 REFN ISSN 0014-5793 REMARK 1 DOI 10.1016/0014-5793(96)00660-6 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.JASKOLSKI,M.KOZAK,J.LUBKOWSKI,G.PALM,A.WLODAWER REMARK 1 TITL STRUCTURES OF TWO HIGHLY HOMOLOGOUS BACTERIAL REMARK 1 TITL 2 L-ASPARAGINASES: A CASE OF ENANTIOMORPHIC SPACE GROUPS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 57 369 2001 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444900020175 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.T.BONTHRON,M.JASKOLSKI REMARK 1 TITL WHY A "BENIGN" MUTATION KILLS ENZYME ACTIVITY. REMARK 1 TITL 2 STRUCTURE-BASED ANALYSIS OF THE A176V MUTANT OF REMARK 1 TITL 3 SACCHAROMYCES CEREVISIAE L-ASPARAGINASE I REMARK 1 REF ACTA BIOCHIM.POL. V. 44 491 1997 REMARK 1 REFN ISSN 0001-527X REMARK 1 REFERENCE 5 REMARK 1 AUTH H.P.AUNG,M.BOCOLA,S.SCHLEPER,K.H.ROHM REMARK 1 TITL DYNAMICS OF A MOBILE LOOP AT THE ACTIVE SITE OF ESCHERICHIA REMARK 1 TITL 2 COLI ASPARAGINASE REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1481 349 2000 REMARK 1 REFN ISSN 0006-3002 REMARK 1 DOI 10.1016/S0167-4838(00)00179-5 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1065 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.23000 REMARK 3 B22 (A**2) : -0.23000 REMARK 3 B33 (A**2) : 0.35000 REMARK 3 B12 (A**2) : -0.12000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.018 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.276 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.209 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.014 ; 0.022 REMARK 3 ANGLE DISTANCE (A) : 1.535 ; 1.952 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 3.768 ; 3.000 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.005 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.098 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.437 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 0.815 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.486 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.483 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 MAXIMUM LIKELIHOOD ALGORITHM. TLS PARAMETERS WERE USED. REMARK 3 RESIDUES 16-34 IN MOLECULE A AND RESIDUES 16-33 IN MOLECULE B NOT REMARK 3 INCLUDED IN THE MODEL DUE TO POOR ELECTRON DENSITY. REMARK 4 REMARK 4 1IHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-APR-01. REMARK 100 THE DEPOSITION ID IS D_1000013268. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-98 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21041 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.54200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: ACTIVE DIMER (AC) FROM NATIVE L-ASPARAGINASE II REMARK 200 STRUCTURE - PDB CODE: 3ECA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, HEPES, PH 7.5, 292 K, REMARK 280 VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.95800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.91600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 55.91600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.95800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 THE BIOLOGICALLY SIGNIFICANT OLIGOMER IS A HOMOTETRAMER REMARK 300 WITH 222 SYMMETRY. THE ASYMMETRIC UNIT CONSIST OF MONOMERS REMARK 300 A AND C WHICH FORM THE ACTIVE-SITE-COMPETENT DIMER WITH REMARK 300 NON-CRYSTALLOGRAPHIC TWO-FOLD SYMMETRY. THE COMPLETE REMARK 300 TETRAMER IS GENERATED FROM THE AC DIMER THROUGH REMARK 300 CRYSTALLOGRAPHIC TWO-FOLD ROTATION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 14310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 83.87400 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 16 REMARK 465 GLY A 17 REMARK 465 ASP A 18 REMARK 465 SER A 19 REMARK 465 ALA A 20 REMARK 465 THR A 21 REMARK 465 LYS A 22 REMARK 465 SER A 23 REMARK 465 ASN A 24 REMARK 465 TYR A 25 REMARK 465 THR A 26 REMARK 465 VAL A 27 REMARK 465 GLY A 28 REMARK 465 LYS A 29 REMARK 465 VAL A 30 REMARK 465 GLY A 31 REMARK 465 VAL A 32 REMARK 465 GLU A 33 REMARK 465 ASN A 34 REMARK 465 GLY C 16 REMARK 465 GLY C 17 REMARK 465 ASP C 18 REMARK 465 SER C 19 REMARK 465 ALA C 20 REMARK 465 THR C 21 REMARK 465 LYS C 22 REMARK 465 SER C 23 REMARK 465 ASN C 24 REMARK 465 TYR C 25 REMARK 465 THR C 26 REMARK 465 VAL C 27 REMARK 465 GLY C 28 REMARK 465 LYS C 29 REMARK 465 VAL C 30 REMARK 465 GLY C 31 REMARK 465 VAL C 32 REMARK 465 GLU C 33 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU C 93 CD GLU C 93 OE1 -0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 78 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 GLU A 93 OE1 - CD - OE2 ANGL. DEV. = -8.2 DEGREES REMARK 500 ASP A 106 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 233 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 285 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 60 CB - CG - OD2 ANGL. DEV. = 6.9 DEGREES REMARK 500 GLU C 93 OE1 - CD - OE2 ANGL. DEV. = -9.2 DEGREES REMARK 500 ASP C 106 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP C 285 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP C 286 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 166 -12.01 -143.44 REMARK 500 THR A 198 -116.00 35.69 REMARK 500 LYS A 251 -67.84 -21.07 REMARK 500 SER A 270 -163.91 -120.53 REMARK 500 ASP A 281 14.57 54.29 REMARK 500 ALA A 282 -72.00 -79.00 REMARK 500 THR C 166 -9.41 -145.13 REMARK 500 THR C 198 -114.06 34.82 REMARK 500 GLU C 210 148.07 -172.38 REMARK 500 LYS C 251 -66.91 -21.08 REMARK 500 SER C 270 -164.55 -123.52 REMARK 500 ASP C 281 15.25 55.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ECA RELATED DB: PDB REMARK 900 STRUCTURE OF NATIVE ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 4ECA RELATED DB: PDB REMARK 900 STRUCTURE OF T89V MUTANT OF ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 1HO3 RELATED DB: PDB REMARK 900 STRUCTURE OF Y25F MUTANT OF ESCHERICHIA COLI ASPARAGINASE II REMARK 900 RELATED ID: 1AGX RELATED DB: PDB REMARK 900 STRUCTURE OF ACINETOBACTER GLUTAMINASIFICANS GLUTAMINASE REMARK 900 ASPARAGINASE REMARK 900 RELATED ID: 1DJO RELATED DB: PDB REMARK 900 STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE REMARK 900 INHIBITOR DONV COVALENTLY BOUND IN THE ACTIVE SITE REMARK 900 RELATED ID: 1DJP RELATED DB: PDB REMARK 900 STRUCTURE OF PSEUDOMONAS 7A GLUTAMINASE-ASPARAGINASE WITH THE REMARK 900 INHIBITOR DON COVALENTLY BOUND IN THE ACTIVE SITE REMARK 900 RELATED ID: 1HFJ RELATED DB: PDB REMARK 900 ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH SULFATE REMARK 900 RELATED ID: 1HFK RELATED DB: PDB REMARK 900 ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH WEAK REMARK 900 SULFATE REMARK 900 RELATED ID: 1WSA RELATED DB: PDB REMARK 900 STRUCTURE OF WOLINELLA SUCCINOGENES L-ASPARAGINASE II PRECURSOR REMARK 900 RELATED ID: 3PGA RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF PSEUDOMONAS 7A GLUTAMINASE- REMARK 900 ASPARAGINASE REMARK 900 RELATED ID: 4PGA RELATED DB: PDB REMARK 900 GLUTAMINASE-ASPARAGINASE FROM PSEUDOMONAS 7A DBREF 1IHD A 1 326 UNP P00805 ASPG2_ECOLI 23 348 DBREF 1IHD C 1 326 UNP P00805 ASPG2_ECOLI 23 348 SEQADV 1IHD GLU A 90 UNP P00805 ASP 112 ENGINEERED MUTATION SEQADV 1IHD GLU C 90 UNP P00805 ASP 112 ENGINEERED MUTATION SEQRES 1 A 326 LEU PRO ASN ILE THR ILE LEU ALA THR GLY GLY THR ILE SEQRES 2 A 326 ALA GLY GLY GLY ASP SER ALA THR LYS SER ASN TYR THR SEQRES 3 A 326 VAL GLY LYS VAL GLY VAL GLU ASN LEU VAL ASN ALA VAL SEQRES 4 A 326 PRO GLN LEU LYS ASP ILE ALA ASN VAL LYS GLY GLU GLN SEQRES 5 A 326 VAL VAL ASN ILE GLY SER GLN ASP MET ASN ASP ASN VAL SEQRES 6 A 326 TRP LEU THR LEU ALA LYS LYS ILE ASN THR ASP CYS ASP SEQRES 7 A 326 LYS THR ASP GLY PHE VAL ILE THR HIS GLY THR GLU THR SEQRES 8 A 326 MET GLU GLU THR ALA TYR PHE LEU ASP LEU THR VAL LYS SEQRES 9 A 326 CYS ASP LYS PRO VAL VAL MET VAL GLY ALA MET ARG PRO SEQRES 10 A 326 SER THR SER MET SER ALA ASP GLY PRO PHE ASN LEU TYR SEQRES 11 A 326 ASN ALA VAL VAL THR ALA ALA ASP LYS ALA SER ALA ASN SEQRES 12 A 326 ARG GLY VAL LEU VAL VAL MET ASN ASP THR VAL LEU ASP SEQRES 13 A 326 GLY ARG ASP VAL THR LYS THR ASN THR THR ASP VAL ALA SEQRES 14 A 326 THR PHE LYS SER VAL ASN TYR GLY PRO LEU GLY TYR ILE SEQRES 15 A 326 HIS ASN GLY LYS ILE ASP TYR GLN ARG THR PRO ALA ARG SEQRES 16 A 326 LYS HIS THR SER ASP THR PRO PHE ASP VAL SER LYS LEU SEQRES 17 A 326 ASN GLU LEU PRO LYS VAL GLY ILE VAL TYR ASN TYR ALA SEQRES 18 A 326 ASN ALA SER ASP LEU PRO ALA LYS ALA LEU VAL ASP ALA SEQRES 19 A 326 GLY TYR ASP GLY ILE VAL SER ALA GLY VAL GLY ASN GLY SEQRES 20 A 326 ASN LEU TYR LYS SER VAL PHE ASP THR LEU ALA THR ALA SEQRES 21 A 326 ALA LYS THR GLY THR ALA VAL VAL ARG SER SER ARG VAL SEQRES 22 A 326 PRO THR GLY ALA THR THR GLN ASP ALA GLU VAL ASP ASP SEQRES 23 A 326 ALA LYS TYR GLY PHE VAL ALA SER GLY THR LEU ASN PRO SEQRES 24 A 326 GLN LYS ALA ARG VAL LEU LEU GLN LEU ALA LEU THR GLN SEQRES 25 A 326 THR LYS ASP PRO GLN GLN ILE GLN GLN ILE PHE ASN GLN SEQRES 26 A 326 TYR SEQRES 1 C 326 LEU PRO ASN ILE THR ILE LEU ALA THR GLY GLY THR ILE SEQRES 2 C 326 ALA GLY GLY GLY ASP SER ALA THR LYS SER ASN TYR THR SEQRES 3 C 326 VAL GLY LYS VAL GLY VAL GLU ASN LEU VAL ASN ALA VAL SEQRES 4 C 326 PRO GLN LEU LYS ASP ILE ALA ASN VAL LYS GLY GLU GLN SEQRES 5 C 326 VAL VAL ASN ILE GLY SER GLN ASP MET ASN ASP ASN VAL SEQRES 6 C 326 TRP LEU THR LEU ALA LYS LYS ILE ASN THR ASP CYS ASP SEQRES 7 C 326 LYS THR ASP GLY PHE VAL ILE THR HIS GLY THR GLU THR SEQRES 8 C 326 MET GLU GLU THR ALA TYR PHE LEU ASP LEU THR VAL LYS SEQRES 9 C 326 CYS ASP LYS PRO VAL VAL MET VAL GLY ALA MET ARG PRO SEQRES 10 C 326 SER THR SER MET SER ALA ASP GLY PRO PHE ASN LEU TYR SEQRES 11 C 326 ASN ALA VAL VAL THR ALA ALA ASP LYS ALA SER ALA ASN SEQRES 12 C 326 ARG GLY VAL LEU VAL VAL MET ASN ASP THR VAL LEU ASP SEQRES 13 C 326 GLY ARG ASP VAL THR LYS THR ASN THR THR ASP VAL ALA SEQRES 14 C 326 THR PHE LYS SER VAL ASN TYR GLY PRO LEU GLY TYR ILE SEQRES 15 C 326 HIS ASN GLY LYS ILE ASP TYR GLN ARG THR PRO ALA ARG SEQRES 16 C 326 LYS HIS THR SER ASP THR PRO PHE ASP VAL SER LYS LEU SEQRES 17 C 326 ASN GLU LEU PRO LYS VAL GLY ILE VAL TYR ASN TYR ALA SEQRES 18 C 326 ASN ALA SER ASP LEU PRO ALA LYS ALA LEU VAL ASP ALA SEQRES 19 C 326 GLY TYR ASP GLY ILE VAL SER ALA GLY VAL GLY ASN GLY SEQRES 20 C 326 ASN LEU TYR LYS SER VAL PHE ASP THR LEU ALA THR ALA SEQRES 21 C 326 ALA LYS THR GLY THR ALA VAL VAL ARG SER SER ARG VAL SEQRES 22 C 326 PRO THR GLY ALA THR THR GLN ASP ALA GLU VAL ASP ASP SEQRES 23 C 326 ALA LYS TYR GLY PHE VAL ALA SER GLY THR LEU ASN PRO SEQRES 24 C 326 GLN LYS ALA ARG VAL LEU LEU GLN LEU ALA LEU THR GLN SEQRES 25 C 326 THR LYS ASP PRO GLN GLN ILE GLN GLN ILE PHE ASN GLN SEQRES 26 C 326 TYR FORMUL 3 HOH *54(H2 O) HELIX 1 1 GLN A 41 ALA A 46 1 6 HELIX 2 2 GLY A 57 MET A 61 5 5 HELIX 3 3 ASN A 62 CYS A 77 1 16 HELIX 4 4 ASP A 78 THR A 80 5 3 HELIX 5 5 THR A 91 VAL A 103 1 13 HELIX 6 6 ASP A 124 ALA A 137 1 14 HELIX 7 7 ASP A 138 ALA A 142 5 5 HELIX 8 8 HIS A 197 THR A 201 5 5 HELIX 9 9 ASP A 225 ALA A 234 1 10 HELIX 10 10 TYR A 250 LYS A 262 1 13 HELIX 11 11 ASP A 285 GLY A 290 1 6 HELIX 12 12 ASN A 298 THR A 311 1 14 HELIX 13 13 ASP A 315 TYR A 326 1 12 HELIX 14 14 ASN C 34 VAL C 39 1 6 HELIX 15 15 GLN C 41 ALA C 46 1 6 HELIX 16 16 GLY C 57 MET C 61 5 5 HELIX 17 17 ASN C 62 CYS C 77 1 16 HELIX 18 18 ASP C 78 THR C 80 5 3 HELIX 19 19 THR C 91 VAL C 103 1 13 HELIX 20 20 ASP C 124 ALA C 137 1 14 HELIX 21 21 ASP C 138 ALA C 142 5 5 HELIX 22 22 HIS C 197 THR C 201 5 5 HELIX 23 23 ASP C 225 ALA C 234 1 10 HELIX 24 24 TYR C 250 THR C 263 1 14 HELIX 25 25 ASP C 285 GLY C 290 1 6 HELIX 26 26 ASN C 298 THR C 311 1 14 HELIX 27 27 ASP C 315 TYR C 326 1 12 SHEET 1 A 8 ASN A 47 GLN A 52 0 SHEET 2 A 8 ASN A 3 ALA A 8 1 N ILE A 4 O ASN A 47 SHEET 3 A 8 GLY A 82 THR A 86 1 O GLY A 82 N THR A 5 SHEET 4 A 8 VAL A 109 VAL A 112 1 O VAL A 110 N ILE A 85 SHEET 5 A 8 LEU A 147 MET A 150 1 N LEU A 147 O VAL A 109 SHEET 6 A 8 THR A 153 ASP A 156 -1 N THR A 153 O MET A 150 SHEET 7 A 8 GLY A 180 HIS A 183 -1 O GLY A 180 N VAL A 154 SHEET 8 A 8 LYS A 186 TYR A 189 -1 O LYS A 186 N HIS A 183 SHEET 1 B 2 VAL A 160 LYS A 162 0 SHEET 2 B 2 PHE A 171 SER A 173 -1 O LYS A 172 N THR A 161 SHEET 1 C 4 VAL A 214 TYR A 218 0 SHEET 2 C 4 GLY A 238 GLY A 243 1 O GLY A 238 N GLY A 215 SHEET 3 C 4 ALA A 266 SER A 271 1 O ALA A 266 N ILE A 239 SHEET 4 C 4 PHE A 291 ALA A 293 1 O VAL A 292 N ARG A 269 SHEET 1 D 8 ASN C 47 GLN C 52 0 SHEET 2 D 8 ASN C 3 ALA C 8 1 N ILE C 4 O ASN C 47 SHEET 3 D 8 GLY C 82 THR C 86 1 O GLY C 82 N THR C 5 SHEET 4 D 8 VAL C 109 VAL C 112 1 O VAL C 110 N ILE C 85 SHEET 5 D 8 LEU C 147 MET C 150 1 O LEU C 147 N MET C 111 SHEET 6 D 8 THR C 153 ASP C 156 -1 N THR C 153 O MET C 150 SHEET 7 D 8 GLY C 180 HIS C 183 -1 O GLY C 180 N VAL C 154 SHEET 8 D 8 LYS C 186 TYR C 189 -1 O LYS C 186 N HIS C 183 SHEET 1 E 2 VAL C 160 LYS C 162 0 SHEET 2 E 2 PHE C 171 SER C 173 -1 O LYS C 172 N THR C 161 SHEET 1 F 4 VAL C 214 TYR C 218 0 SHEET 2 F 4 GLY C 238 GLY C 243 1 O GLY C 238 N GLY C 215 SHEET 3 F 4 ALA C 266 SER C 271 1 O ALA C 266 N ILE C 239 SHEET 4 F 4 PHE C 291 ALA C 293 1 O VAL C 292 N ARG C 269 SSBOND 1 CYS A 77 CYS A 105 1555 1555 1.99 SSBOND 2 CYS C 77 CYS C 105 1555 1555 1.97 CRYST1 123.255 123.255 83.874 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008113 0.004684 0.000000 0.00000 SCALE2 0.000000 0.009368 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011923 0.00000